EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Subcellular expression of CD30 in cutaneous mastocytosis—An important factor for targeted treatment

Christina Mitteldorf, Aleksandra Kulberg, Michael Tronnier, Michael P Schön, Werner Kempf

Journal of Cutaneous Pathology · 2024

DOI: 10.1111/cup.14695 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Christina Mitteldorf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Ki-1 Antigen, Mastocytosis, Cutaneous, Mast Cells, Eosinophils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Helios Forschungsförderung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The subcellular distribution of CD30 on mast cells and the presence of eosinophils in cutaneous mastocytosis require further investigation, especially as the cell surface expression of CD30 is critical for the therapeutic response of systemic mastocytosis to brentuximab vedotin.

Objective

Investigation of 147 biopsy specimens from 143 patients with cutaneous mastocytosis for mast cell density and distribution, frequency of CD30 expression, CD30 staining patterns, and presence and distribution of eosinophils. Correlation with clinical patterns.

Methods

Retrospective multicenter immunohistochemical study of CD30 expression, eosinophils and basic clinical data in cutaneous mastocytosis.

Results

CD30 expression was found in all samples (cut‐off: ≥1%), whereby the staining was predominantly cytoplasmic in 99% of the samples. Additional membrane staining was detected in 62% of the samples. Surface expression of CD30 was more common in biopsy specimens with a high mast cell burden and in biopsy specimens with a higher CD30 expression rate. Eosinophils were admixed in 58% of the samples. Females and older patients showed a trend of a lower mast cell burden.

Limitations

Retrospective study on formalin‐fixed and paraffin‐embedded tissue without functional analysis.

Conclusion

Most cases of cutaneous mastocytosis show cell surface expression of CD30 expression and is, therefore, in principle, accessible for therapy with antibodies against CD30, provided the overall situation of the patient warrants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-1 AntigenMastocytosis, CutaneousMast CellsEosinophilsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedAged, 80 and overAdolescentChildChild, PreschoolYoung AdultBiopsyImmunohistochemistry

Stichwörter der Autor:innen

CD30 patternbrentuximab vedotincytoplasmiceosinophilsmembranesurfacetherapeutic response

Substanzen

Ki-1 Antigen

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Dermatology, Venereology and Allergology, Helios Klinikum Hildesheim, Hildesheim, Germany.
  • Kempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland.
  • Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.

Förderung

  • Helios Forschungsförderung

Zitieren

APA

Mitteldorf, C., Kulberg, A., Tronnier, M., Schön, M. P., & Kempf, W. (2024). Subcellular expression of CD30 in cutaneous mastocytosis—An important factor for targeted treatment. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14695

Vancouver

Mitteldorf C, Kulberg A, Tronnier M, Schön MP, Kempf W. Subcellular expression of CD30 in cutaneous mastocytosis—An important factor for targeted treatment. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14695

BibTeX
@article{Mitteldorf2024,
  author = {Mitteldorf, Christina and Kulberg, Aleksandra and Tronnier, Michael and Schön, Michael P and Kempf, Werner},
  title = {Subcellular expression of CD30 in cutaneous mastocytosis—An important factor for targeted treatment},
  journal = {Journal of Cutaneous Pathology},
  year = {2024},
  doi = {10.1111/cup.14695}
}
Kostenlos starten →